84 related articles for article (PubMed ID: 38529388)
1. Cost-effective prognostic evaluation of breast cancer: using a STAR nomogram model based on routine blood tests.
Wei C; Liang Y; Mo D; Lin Q; Liu Z; Li M; Qin Y; Fang M
Front Endocrinol (Lausanne); 2024; 15():1324617. PubMed ID: 38529388
[TBL] [Abstract][Full Text] [Related]
2. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a
Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.
Wang H; Xia GF; Zhang ZR; Luo X; Zhu JY; Wang HK
Am J Cancer Res; 2023; 13(11):5065-5081. PubMed ID: 38058820
[TBL] [Abstract][Full Text] [Related]
5. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information.
Wang Y; Ali MA; Vallon-Christersson J; Humphreys K; Hartman J; Rantalainen M
Eur J Cancer; 2023 Sep; 191():112953. PubMed ID: 37494846
[TBL] [Abstract][Full Text] [Related]
8. The prognosis of breast cancer patients with bone metastasis could be potentially estimated based on blood routine test and biochemical examination at admission.
Huang B; Wu FC; Wang WD; Shao BQ; Wang XM; Lin YM; Zheng GX; Dong MM; Liu CT; Xu YW; Wang XJ
Ann Med; 2023 Dec; 55(1):2231342. PubMed ID: 37395196
[TBL] [Abstract][Full Text] [Related]
9.
Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
[TBL] [Abstract][Full Text] [Related]
10. Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer.
Čelešnik H; Potočnik U
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831426
[TBL] [Abstract][Full Text] [Related]
11. The majority of 922 prediction models supporting breast cancer decision-making are at high risk of bias.
Hueting TA; van Maaren MC; Hendriks MP; Koffijberg H; Siesling S
J Clin Epidemiol; 2022 Dec; 152():238-247. PubMed ID: 36633901
[TBL] [Abstract][Full Text] [Related]
12. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
13. Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?
Mao JR; Lan KQ; Liu SL; Liu C; Xie SY; Li SC; Ye WF; Sun XS; Mai HQ
Radiother Oncol; 2023 Feb; 179():109445. PubMed ID: 36566987
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
